Literature DB >> 21658523

Patient utilization of cognitive-behavioral therapy for OCD.

Maria C Mancebo1, Jane L Eisen, Nicholas J Sibrava, Ingrid R Dyck, Steven A Rasmussen.   

Abstract

The current study examined utilization of cognitive-behavioral therapy (CBT) by individuals receiving treatment for obsessive-compulsive disorder (OCD). Participants were 202 adults with primary DSM-IV OCD who enrolled in a longitudinal, observational study of the course of OCD and completed 2 years of annual follow-up interviews using the Longitudinal Interval Follow-Up Evaluation. One hundred twenty participants reported that a mental health professional recommended CBT for their OCD symptoms at some point during the 2-year follow-up period. One quarter (n = 31) of these participants did not initiate CBT despite receiving a treatment recommendation. Thirty-one percent of the 89 participants who entered CBT endorsed dropping out of CBT prematurely and less than one third received an adequate "dose" of CBT sessions. Self-reported CBT drop-out rates were significantly greater than attrition rates reported in clinical trials using intensive schedules of exposure and ritual prevention (EX/RP). Perceived environmental barriers and fears regarding treatment participation were the most frequently endorsed reasons for not participating or dropping out of CBT. Despite its efficacy for OCD, many individuals with clinically significant symptoms fail to initiate CBT when recommended by a mental health professional, receive treatments that are less intensive than those used in clinical trials, or drop out of treatment prematurely. Financial costs of CBT, difficulty attending sessions, and fears regarding treatment are significant barriers to initiating and completing therapy.
Copyright © 2011. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21658523      PMCID: PMC3857709          DOI: 10.1016/j.beth.2010.10.002

Source DB:  PubMed          Journal:  Behav Ther        ISSN: 0005-7894


  38 in total

1.  A rating scale for depression.

Authors:  M HAMILTON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1960-02       Impact factor: 10.154

Review 2.  Practice guideline for the treatment of patients with obsessive-compulsive disorder.

Authors:  Lorrin M Koran; Gregory L Hanna; Eric Hollander; Gerald Nestadt; Helen Blair Simpson
Journal:  Am J Psychiatry       Date:  2007-07       Impact factor: 18.112

3.  The brown longitudinal obsessive compulsive study: treatments received and patient impressions of improvement.

Authors:  Maria C Mancebo; Jane L Eisen; Anthony Pinto; Benjamin D Greenberg; Ingrid R Dyck; Steven A Rasmussen
Journal:  J Clin Psychiatry       Date:  2006-11       Impact factor: 4.384

4.  Patterns of remission and relapse in obsessive-compulsive disorder: a 2-year prospective study.

Authors:  J L Eisen; W K Goodman; M B Keller; M G Warshaw; L M DeMarco; D D Luce; S A Rasmussen
Journal:  J Clin Psychiatry       Date:  1999-05       Impact factor: 4.384

5.  A brief motivational intervention for treatment-refusing OCD patients.

Authors:  Nicholas Maltby; David F Tolin
Journal:  Cogn Behav Ther       Date:  2005

6.  Cognitive therapy and exposure in vivo alone and in combination with fluvoxamine in obsessive-compulsive disorder: a 5-year follow-up.

Authors:  Patricia van Oppen; Anton J L M van Balkom; Else de Haan; Richard van Dyck
Journal:  J Clin Psychiatry       Date:  2005-11       Impact factor: 4.384

7.  A multidimensional meta-analysis of psychotherapy and pharmacotherapy for obsessive-compulsive disorder.

Authors:  Kamryn T Eddy; Lissa Dutra; Rebekah Bradley; Drew Westen
Journal:  Clin Psychol Rev       Date:  2004-12

8.  Home self-assessment and self-treatment of obsessive-compulsive disorder using a manual and a computer-conducted telephone interview: replication of a UK-US study.

Authors:  M Bachofen; A Nakagawa; I M Marks; J M Park; J H Greist; L Baer; K W Wenzel; J R Parkin; S L Dottl
Journal:  J Clin Psychiatry       Date:  1999-08       Impact factor: 4.384

9.  Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder.

Authors:  Edna B Foa; Michael R Liebowitz; Michael J Kozak; Sharon Davies; Rafael Campeas; Martin E Franklin; Jonathan D Huppert; Kevin Kjernisted; Vivienne Rowan; Andrew B Schmidt; H Blair Simpson; Xin Tu
Journal:  Am J Psychiatry       Date:  2005-01       Impact factor: 18.112

10.  A randomized controlled trial of self-directed versus therapist-directed cognitive-behavioral therapy for obsessive-compulsive disorder patients with prior medication trials.

Authors:  David F Tolin; Scott Hannan; Nicholas Maltby; Gretchen J Diefenbach; Patrick Worhunsky; Robert E Brady
Journal:  Behav Ther       Date:  2007-01-23
View more
  13 in total

1.  Advances in the treatment of pediatric obsessive-compulsive d-cycloserine with exposure and response prevention.

Authors:  Joseph F McGuire; Adam B Lewin; Daniel A Geller; Ashley Brown; Kesley Ramsey; Jane Mutch; Andrew Mittelman; Jamie Micco; Cary Jordan; Sabine Wilhelm; Tanya K Murphy; Brent J Small; Eric A Storch
Journal:  Neuropsychiatry (London)       Date:  2012-08

2.  Prediction of remission in obsessive compulsive disorder using a novel machine learning strategy.

Authors:  Kathleen D Askland; Sarah Garnaat; Nicholas J Sibrava; Christina L Boisseau; David Strong; Maria Mancebo; Benjamin Greenberg; Steve Rasmussen; Jane Eisen
Journal:  Int J Methods Psychiatr Res       Date:  2015-05-21       Impact factor: 4.035

Review 3.  Excluding the typical patient: thirty years of pharmacotherapy efficacy trials for obsessive-compulsive disorder.

Authors:  Brian L Odlaug; Eric Weinhandl; Maria C Mancebo; Erik L Mortensen; Jane L Eisen; Steven A Rasmussen; Liana R N Schreiber; Jon E Grant
Journal:  Ann Clin Psychiatry       Date:  2014-02       Impact factor: 1.567

4.  Innovations in the Delivery of Exposure and Response Prevention for Obsessive-Compulsive Disorder.

Authors:  Sapana R Patel; Jonathan Comer; Helen Blair Simpson
Journal:  Curr Top Behav Neurosci       Date:  2021

Review 5.  The prefrontal cortex and neurosurgical treatment for intractable OCD.

Authors:  Steven A Rasmussen; Wayne K Goodman
Journal:  Neuropsychopharmacology       Date:  2021-08-25       Impact factor: 7.853

6.  Who qualifies for deep brain stimulation for OCD? Data from a naturalistic clinical sample.

Authors:  Sarah L Garnaat; Benjamin D Greenberg; Nicholas J Sibrava; Wayne K Goodman; Maria C Mancebo; Jane L Eisen; Steven A Rasmussen
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2014       Impact factor: 2.198

7.  Multidimensional Approaches for A Case of Severe Adult Obsessive - Compulsive Disorder.

Authors:  Zhongyong Shi; Xinchun Mei; Yingbo Zhu; Yu Shuai; Yupeng Chen; Yujie Wu; Yuan Shen
Journal:  Shanghai Arch Psychiatry       Date:  2017-10-25

8.  Metacognitive Training for Obsessive-Compulsive Disorder: a study protocol for a randomized controlled trial.

Authors:  Franziska Miegel; Cüneyt Demiralay; Steffen Moritz; Janina Wirtz; Birgit Hottenrott; Lena Jelinek
Journal:  BMC Psychiatry       Date:  2020-07-06       Impact factor: 3.630

9.  'One man's medicine is another man's poison': a qualitative study of user perspectives on low intensity interventions for Obsessive-Compulsive Disorder (OCD).

Authors:  Jasmin Knopp-Hoffer; Sarah Knowles; Peter Bower; Karina Lovell; Penny E Bee
Journal:  BMC Health Serv Res       Date:  2016-05-18       Impact factor: 2.655

10.  Cost-effectiveness of internet-based cognitive-behavioural therapy for obsessive-compulsive disorder.

Authors:  Debra Osborne; Denny Meyer; Richard Moulding; Michael Kyrios; Eleanor Bailey; Maja Nedeljkovic
Journal:  Internet Interv       Date:  2019-09-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.